PharmiWeb.com - Global Pharma News & Resources
30-Oct-2018

Global Pain Management Drugs Market Analysis 2018 - Forecast to 2025 - ResearchAndMarkets.com

The "Global Pain Management Drugs Market Analysis 2018 - Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.

The report contains up to date financial data derived from varied research sources to present unique and reliable analysis.
Assessment of major trends with potential impact on the market during the next eight years, including a deep dive analysis of market segmentation which comprises of sub markets, regional and country level analysis.
The report provides a comprehensive outlook about the market share along with strategic recommendations based on the emerging segments.


This report provides:

  • Market Sizing estimations and forecasts across the given market segments
  • Identifying market dynamics (Drivers, Restraints, Opportunities, Threats, Challenges and Opportunities)
  • Strategic recommendations in key business segments based on the market estimations
  • Regional and country level market analysis
  • Competitive landscaping of major market players
  • Company profiling covering the financials, recent activities and the future strategies

Key Topics Covered

1 Introduction

2 Executive Summary

3 Market Analysis

4 Porters Five Force Analysis

5 Pain Management Drugs Market by Category

6 Pain Management Drugs Market by Distribution Channel

7 Pain Management Drugs Market by Brands

8 Pain Management Drugs Market by Drug Class

9 Pain Management Drugs Market by Therapeutic Indications

10 Geographical Segmentation

11 Vendor Landscaping

12 Company Profiles

  • Valeant Pharmaceuticals International Inc.
  • Endo International PLC
  • Johnson & Johnson
  • Roche Holding AG
  • GlaxoSmithKline PLC (GSK)
  • Merck & Co. Inc.
  • AstraZeneca PLC
  • Pfizer Inc.
  • Sanofi S.A.
  • Mylan N.V.
  • Teva Pharmaceutical Industries Ltd.
  • Eily, Lilly and Company
  • Abbott Laboratories
  • Purdue Pharma L.P.
  • Novartis AG
  • Baxter International Inc.
  • Wex Pharmaceuticals Inc.

For more information about this report visit https://www.researchandmarkets.com/research/l6hxqj/global_pain?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20181030005593/en/

Editor Details

Last Updated: 30-Oct-2018